2,747
Views
7
CrossRef citations to date
0
Altmetric
Systematic review

Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review

ORCID Icon, , &
Pages 235-245 | Received 14 Nov 2020, Accepted 22 Jan 2021, Published online: 23 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Claire E. Mellott, Rafal Jaworski, Justin Carrico, Sandra E. Talbird, Iwona Dobrowolska, Dominik Golicki, Goran Bencina, Micah Clinkscales, Eugenia Karamousouli, Amanda L Eiden & Ugne Sabale. (2023) Public health impact and return on investment of the pediatric immunization program in Poland. Expert Review of Vaccines 22:1, pages 1114-1125.
Read now

Articles from other publishers (6)

Deepshikha Sharma, Shankar Prinja, Arun K. Aggarwal, Kavitha Rajsekar & Pankaj Bahuguna. (2023) Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment. The Lancet Regional Health - Southeast Asia 16, pages 100241.
Crossref
Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Toshiaki Murofushi, Michael LoPresti, Ankush Taneja, Jake Horgan & Shunya Ikeda. (2022) Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders. Advances in Therapy 39:12, pages 5327-5350.
Crossref
Shan Jiang, Yitong Wang, Lei Si, Xiao Zang, Yuan-Yuan Gu, Yawen Jiang, Gordon G Liu & Jing Wu. (2022) Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China. BMJ Global Health 7:8, pages e009777.
Crossref
M.K. Rasmussen, C. Kronborg, I. Fasterholdt & K. Kidholm. (2022) Economic evaluations of interventions against viral pandemics: a scoping review. Public Health 208, pages 72-79.
Crossref
Ekkehard Beck, Eliana Biundo, Nancy Devlin, T. Mark Doherty, Antonio J. Garcia-Ruiz, Maarten Postma, Shazia Sheikh, Beata Smela, Mondher Toumi, Jurgen Wasem, Terry Nolan & David Salisbury. (2022) Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework. Vaccine 40:30, pages 4008-4016.
Crossref
Michele A. Kohli, Michael Maschio, Joaquin F. Mould-Quevedo, Mansoor Ashraf, Michael F. Drummond & Milton C. Weinstein. (2021) The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom. Vaccines 9:6, pages 598.
Crossref